Intrathecal Hydromorphone for Labor Analgesia
| Status: | Recruiting |
|---|---|
| Conditions: | Women's Studies |
| Therapuetic Areas: | Reproductive |
| Healthy: | No |
| Age Range: | 18 - 45 |
| Updated: | 1/24/2018 |
| Start Date: | September 2015 |
| End Date: | December 2019 |
| Contact: | Dominique Arce, MD |
| Email: | DArce@bwh.harvard.edu |
| Phone: | 617-732-8220 |
The objective of this study is to evaluate the effect of intrathecal hydromorphone on the
duration of labor analgesia and the incidence of epidural-associated temperature increase in
laboring parturients. We hypothesize that intrathecal administration of longer-acting
hydromorphone will:
1. Prolong the duration and improve the quality of analgesia in labor, and
2. Decrease the incidence of epidural-associated temperature increase in labor.
duration of labor analgesia and the incidence of epidural-associated temperature increase in
laboring parturients. We hypothesize that intrathecal administration of longer-acting
hydromorphone will:
1. Prolong the duration and improve the quality of analgesia in labor, and
2. Decrease the incidence of epidural-associated temperature increase in labor.
Inclusion Criteria:
- Patients are eligible for enrollment if they are healthy, pregnant females between the
ages of 18 and 45 years, primiparous, and at term gestation (≥ 37 weeks).
Exclusion Criteria:
- Patients with a Category II or III fetal heart rate tracing, a fetus with intrauterine
growth restriction, prolonged rupture of membranes, recent diagnosis of infection of
any cause, or in whom dural puncture is contraindicated will be excluded from the
study.
We found this trial at
1
site
75 Francis street
Boston, Massachusetts 02115
Boston, Massachusetts 02115
(617) 732-5500
Principal Investigator: Dominique Arce, MD
Phone: 617-732-8220
Brigham and Women's Hosp Boston’s Brigham and Women’s Hospital (BWH) is an international leader in...
Click here to add this to my saved trials
